A Reliance Capital Company
Company Search 43
Open an Account  | Login  | Demo
Wednesday, December 05, 2007
Real news in Real Time! National and international updates on all products by leading agencies such as Dow Jones, Capital Markets, Commodities Control and more.
Equity   |   Derivatives   |   IPO   |   Commodity   |   Mutual Funds   |   Forex   |   Insurance   |   Mobile

OVERVIEW

Capital Market Live News    Dow Jones News Wire    Derivatives/F&O News    Advanced Search   
Commodity News    Forex News   


Capital Market Live News
Dec 3 2007 5:39PM
Ankur Drugs & Pharma recommends dividend
The board of Ankur Drugs & Pharma has recommended dividend at the rate of 20% for financial year ended 2006-2007.

This was recommended at the board meeting held on 30 November 2007.

Powered byCapital Market - Live News
  Source:   

   Capital Market Disclaimer
Back
 
 
News
 
Research
 
Markets
 
Knowledge Center
 
Charting
 
Customer Service
 
Contact Us
 
Site Map
 
SEBI | BSE | NSE
Terms & Conditions | Disclaimer | Online Privacy | Trouble Logging in
Copyright© 2007. All rights Reserved. Reliance Money Limited
Equities: Trading through Reliance Securities Limited | NSE SEBI Registration Number Capital Market :- INB 231234833 | BSE SEBI
Registration Number Capital Market :- INB 011234839 | NSE SEBI Registration Number Derivatives :- INF 231234833 Commodities : Trading through Reliance Commodities Limited | MCX member code: 29030 | NCDEX member code: NCDEX-CO-05-00647|
NMCE member code: CL0120 Mutual Funds : Reliance Securities Limited | AMFI ARN No.29889
In case of any grievances please write to [email protected]
In case of any queries/ complaints with respect to stock broking transactions executed on this website or pertaining account opening, Pl.address your correspondence to Reliance Securities Limited.